Names | |
---|---|
IUPAC name
3-[3-[4-(4-Bromophenyl)phenyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-hydroxychromen-4-one
| |
Other names
Bromfenacoum
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.054.509 |
PubChem CID
|
|
RTECS number |
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C31H23BrO3 | |
Molar mass | 523.426 g·mol−1 |
Melting point | 228 to 230 °C (442 to 446 °F; 501 to 503 K) |
Insoluble | |
Pharmacology | |
Oral; dermal; inhalation (dusts) (for poisoning) | |
Pharmacokinetics: | |
100% | |
slow, incomplete, hepatic | |
Slow; 20—130 days | |
faeces; very slow | |
Hazards | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
270 μg/kg (rat, oral) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Brodifacoum is a highly lethal 4-hydroxycoumarin vitamin K antagonist anticoagulant poison. In recent years, it has become one of the world's most widely used pesticides. It is typically used as a rodenticide, but is also used to control larger pests such as possums.[2]
Brodifacoum has an especially long half-life in the body, which ranges up to nine months, requiring prolonged treatment with antidotal vitamin K for both human and pet poisonings. It has one of the highest risks of secondary poisoning to both mammals and birds.[3] Significant experience in brodifacoum poisonings has been gained in many human cases where it has been used in attempted suicides, necessitating long periods of vitamin K treatment. In March 2018, cases of severe coagulopathy and bleeding associated with synthetic cannabinoid use contaminated with brodifacoum were reported in five states of the US.